Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Benjamin

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
BJU International|May 10, 2025
Precision medicine in genitourinary oncology: are we pivoting towards imprecision?David J Benjamin, Arash Rezazadeh Kalebasty
Nature Reviews. Urology|April 3, 2023
Patient preferences in the treatment of genitourinary cancersDavid J Benjamin, Arash Rezazadeh Kalebasty
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2024
From Comfort to Cure: Re-Emphasizing Supportive and Palliative Care in OncologyDavid J Benjamin, Mark P Lythgoe
Frontiers in Oncology|January 30, 2025
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapyDavid J Benjamin, Robert C Hsu
Nature Reviews. Urology|March 17, 2023
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatmentKyle Nolla, David J Benjamin, David Cella
Cancer Drug Resistance (Alhambra, Calif.)|February 11, 2025
The emerging role of GLP-1 receptor agonists in treating or preventing cancerDavid J Benjamin, Daniel D Von Hoff
Cancers|July 29, 2023
The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative ReviewRobert Hsu, David J Benjamin, Misako Nagasaka
Future Oncology (London, England)|January 19, 2023
Nivolumab plus cabozantinib for advanced renal cell carcinomaDavid J Benjamin, Kyle Nolla, David Cella
Cancer Medicine|March 16, 2024
Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trialsDavid J Benjamin, Alyson Haslam, Vinay Prasad
JCO Global Oncology|February 27, 2025
Gender and Geographic Characteristics Among Thoracic, GI, and Breast Oncology Editorial Boards: Disparities and Measures to Address GapsRobert Hsu, Zhaohui Liao Arter, David J Benjamin
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
BJU International|May 10, 2025
Precision medicine in genitourinary oncology: are we pivoting towards imprecision?David J Benjamin, Arash Rezazadeh Kalebasty
Nature Reviews. Urology|April 3, 2023
Patient preferences in the treatment of genitourinary cancersDavid J Benjamin, Arash Rezazadeh Kalebasty
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2024
From Comfort to Cure: Re-Emphasizing Supportive and Palliative Care in OncologyDavid J Benjamin, Mark P Lythgoe
Frontiers in Oncology|January 30, 2025
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapyDavid J Benjamin, Robert C Hsu
Nature Reviews. Urology|March 17, 2023
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatmentKyle Nolla, David J Benjamin, David Cella
Cancer Drug Resistance (Alhambra, Calif.)|February 11, 2025
The emerging role of GLP-1 receptor agonists in treating or preventing cancerDavid J Benjamin, Daniel D Von Hoff
Cancers|July 29, 2023
The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative ReviewRobert Hsu, David J Benjamin, Misako Nagasaka
Future Oncology (London, England)|January 19, 2023
Nivolumab plus cabozantinib for advanced renal cell carcinomaDavid J Benjamin, Kyle Nolla, David Cella
Cancer Medicine|March 16, 2024
Cardiovascular/anti-inflammatory drugs repurposed for treating or preventing cancer: A systematic review and meta-analysis of randomized trialsDavid J Benjamin, Alyson Haslam, Vinay Prasad
JCO Global Oncology|February 27, 2025
Gender and Geographic Characteristics Among Thoracic, GI, and Breast Oncology Editorial Boards: Disparities and Measures to Address GapsRobert Hsu, Zhaohui Liao Arter, David J Benjamin
Pageof 9